177 related articles for article (PubMed ID: 22248821)
1. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome.
Boudreau EF; Josleyn M; Ullman D; Fisher D; Dalrymple L; Sellers-Myers K; Loudon P; Rusnak J; Rivard R; Schmaljohn C; Hooper JW
Vaccine; 2012 Mar; 30(11):1951-8. PubMed ID: 22248821
[TBL] [Abstract][Full Text] [Related]
2. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation.
Hooper JW; Moon JE; Paolino KM; Newcomer R; McLain DE; Josleyn M; Hannaman D; Schmaljohn C
Clin Microbiol Infect; 2014 May; 20 Suppl 5():110-7. PubMed ID: 24447183
[TBL] [Abstract][Full Text] [Related]
3. Mixing of M segment DNA vaccines to Hantaan virus and Puumala virus reduces their immunogenicity in hamsters.
Spik KW; Badger C; Mathiessen I; Tjelle T; Hooper JW; Schmaljohn C
Vaccine; 2008 Sep; 26(40):5177-81. PubMed ID: 18482782
[TBL] [Abstract][Full Text] [Related]
4. DNA vaccines for HFRS: laboratory and clinical studies.
Schmaljohn CS; Spik KW; Hooper JW
Virus Res; 2014 Jul; 187():91-6. PubMed ID: 24370868
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of a multi-epitope DNA vaccine against hantavirus.
Zhao C; Sun Y; Zhao Y; Wang S; Yu T; Du F; Yang XF; Luo E
Hum Vaccin Immunother; 2012 Feb; 8(2):208-15. PubMed ID: 22426376
[TBL] [Abstract][Full Text] [Related]
6. A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).
Hooper JW; Josleyn M; Ballantyne J; Brocato R
Vaccine; 2013 Sep; 31(40):4314-21. PubMed ID: 23892100
[TBL] [Abstract][Full Text] [Related]
7. The assessment of Hantaan virus-specific antibody responses after the immunization program for hemorrhagic fever with renal syndrome in northwest China.
Li Z; Zeng H; Wang Y; Zhang Y; Cheng L; Zhang F; Lei Y; Jin B; Ma Y; Chen L
Hum Vaccin Immunother; 2017 Apr; 13(4):802-807. PubMed ID: 27824286
[TBL] [Abstract][Full Text] [Related]
8. Construction and nonclinical testing of a Puumala virus synthetic M gene-based DNA vaccine.
Brocato RL; Josleyn MJ; Wahl-Jensen V; Schmaljohn CS; Hooper JW
Clin Vaccine Immunol; 2013 Feb; 20(2):218-26. PubMed ID: 23239797
[TBL] [Abstract][Full Text] [Related]
9. DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys.
Hooper JW; Custer DM; Thompson E; Schmaljohn CS
J Virol; 2001 Sep; 75(18):8469-77. PubMed ID: 11507192
[TBL] [Abstract][Full Text] [Related]
10. [A study on immunogenicity and safety of bivalent inactivated vaccine against hemorrhagic fever with renal syndrome].
Ruan Y; Xu X; Liu W; Deng X; Weng S; Zhou W; Wang Q; Chen L; Fang L; Xu Z; Yan Q; Liu W; Dong G; Gu H; Yu Y; Xu Z
Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Nov; 33(6):340-2. PubMed ID: 11864504
[TBL] [Abstract][Full Text] [Related]
11. Analysis of immune responses against nucleocapsid protein of the Hantaan virus elicited by virus infection or DNA vaccination.
Woo GJ; Chun EY; Kim KH; Kim W
J Microbiol; 2005 Dec; 43(6):537-45. PubMed ID: 16410771
[TBL] [Abstract][Full Text] [Related]
12. Long-term immunogenicity and safety of inactivated Hantaan virus vaccine (Hantavax™) in healthy adults.
Song JY; Woo HJ; Cheong HJ; Noh JY; Baek LJ; Kim WJ
Vaccine; 2016 Mar; 34(10):1289-95. PubMed ID: 26826547
[TBL] [Abstract][Full Text] [Related]
13. A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.
McCoy JR; Mendoza JM; Spik KW; Badger C; Gomez AF; Schmaljohn CS; Sardesai NY; Broderick KE
Hum Vaccin Immunother; 2014; 10(10):3039-47. PubMed ID: 25483486
[TBL] [Abstract][Full Text] [Related]
14. Investigation on inactivated epidemic hemorrhagic fever tissue culture vaccine in humans.
Zhu ZY; Tang HY; Li YJ; Weng JQ; Yu YX; Zeng RF
Chin Med J (Engl); 1994 Mar; 107(3):167-70. PubMed ID: 7916278
[TBL] [Abstract][Full Text] [Related]
15. [Immunogenicity of N-protein of Puumala hantavirus for noninbred mice in the intramuscular administration of its gene DNA].
Chubukova OV; Khasanova SS; Nikonorov IuM; Kulagin VF; Chemeris AV; Vakhitov VA
Vopr Virusol; 2008; 53(4):38-41. PubMed ID: 18756816
[TBL] [Abstract][Full Text] [Related]
16. [Serological surveillance on vaccine against hemorrhagic fever with renal syndrome].
Gong ZY; Weng JQ; Zhao ZY; Chen YT; Zhu AG; Fu GM; Fang CF; Zhu ZY; Chen EF; Wang CZ; Wang W; Lei LH; Wang Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):400-2. PubMed ID: 15231163
[TBL] [Abstract][Full Text] [Related]
17. [Passage adaptability of candidate strains for hemorrhagic fever with renal syndrome purified vaccine in Vero cells and their immunogenicity].
Chen W; Xue CF; Liu JQ; Li ZY; Fan YX; Xu L; Liao H
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):129-32. PubMed ID: 12869992
[TBL] [Abstract][Full Text] [Related]
18. A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus.
Chu YK; Jennings GB; Schmaljohn CS
J Virol; 1995 Oct; 69(10):6417-23. PubMed ID: 7666542
[TBL] [Abstract][Full Text] [Related]
19. [Preventive effects of three kinds of inactive vaccines against epidemic hemorrhagic fever (EHF) after 5 years of vaccination].
Chen H; Tang L; Luo Z; Zhang J; Zhang Z; Hu M; Weng J; Liu W; Zhao T; Liu W
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Oct; 21(5):347-8. PubMed ID: 11860813
[TBL] [Abstract][Full Text] [Related]
20. Specific humoral reaction of hemorrhagic fever with renal syndrome (HFRS) patients in China to recombinant nucleocapsid proteins from European hantaviruses.
Xiong HR; Li Q; Chen W; Liu DY; Ling JX; Liu J; Liu YJ; Zhang Y; Yang ZQ
Eur J Clin Microbiol Infect Dis; 2011 May; 30(5):645-51. PubMed ID: 21222012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]